These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 3034022

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
    Vasmant D, Bender N.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
    [Abstract] [Full Text] [Related]

  • 7. Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension.
    Stumpe KO, Overlack A, Kolloch R, Schatz J, Witte PU, Pahnke K.
    Klin Wochenschr; 1986 Jun 16; 64(12):558-62. PubMed ID: 3016405
    [Abstract] [Full Text] [Related]

  • 8. Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension.
    Lenz T, Distler A, Haller H, Meyer-Sabellek W, Wilp C, Tansey MJ, Eckert HG, Metzger H, Irmisch R, Philipp T.
    Arzneimittelforschung; 1986 Nov 16; 36(11):1693-6. PubMed ID: 3028438
    [Abstract] [Full Text] [Related]

  • 9. Effect of ramipril, a new angiotensin converting enzyme inhibitor, on diurnal variations of blood pressure in essential hypertension.
    Kaneko Y, Omae T, Yoshinaga K, Iimura O, Inagaki Y, Ishii M, Saruta T, Yamada K, Kumahara Y, Ito K.
    Am J Cardiol; 1987 Apr 24; 59(10):86D-91D. PubMed ID: 3034040
    [Abstract] [Full Text] [Related]

  • 10. Acute hemodynamic, hormonal and electrolyte effects of ramipril in severe congestive heart failure.
    Crozier IG, Ikram H, Nicholls MG, Jans S.
    Am J Cardiol; 1987 Apr 24; 59(10):155D-163D. PubMed ID: 3034025
    [Abstract] [Full Text] [Related]

  • 11. Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important.
    Wenting GJ, Blankestijn PJ, Poldermans D, van Geelen J, Derkx FH, Man in't Veld AJ, Schalekamp MA.
    Am J Cardiol; 1987 Apr 24; 59(10):92D-97D. PubMed ID: 3034041
    [Abstract] [Full Text] [Related]

  • 12. Enalapril in the treatment of hypertension with renal artery stenosis.
    Hodsman GP, Brown JJ, Cumming AM, Davies DL, East BW, Lever AF, Morton JJ, Murray GD, Robertson I, Robertson JI.
    Br Med J (Clin Res Ed); 1983 Nov 12; 287(6403):1413-7. PubMed ID: 6315126
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
    Moursi MG, Ganten D, Lang RE, Unger T.
    J Hypertens Suppl; 1986 Oct 12; 4(3):S495-8. PubMed ID: 3023591
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic efficacy and tolerance of ramipril in hypertensive patients with renal failure.
    Kindler J, Schunkert H, Gassmann M, Lahn W, Irmisch R, Debusmann ER, Ocón-Pujadas J, Ritz E, Sieberth HG.
    J Cardiovasc Pharmacol; 1989 Oct 12; 13 Suppl 3():S55-8. PubMed ID: 2474105
    [Abstract] [Full Text] [Related]

  • 15. Short- and long-term effects of ramipril in hypertension.
    de Leeuw PW, Birkenhäger WH.
    Am J Cardiol; 1987 Apr 24; 59(10):79D-82D. PubMed ID: 3034038
    [Abstract] [Full Text] [Related]

  • 16. Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.
    Hodsman GP, Brown JJ, Davies DL, Fraser R, Lever AF, Morton JJ, Murray GD, Robertson JI.
    Br Med J (Clin Res Ed); 1982 Dec 11; 285(6356):1697-9. PubMed ID: 6293638
    [Abstract] [Full Text] [Related]

  • 17. First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril.
    Heber ME, Brigden GS, Caruana MP, Lahiri A, Raftery EB.
    Am J Cardiol; 1988 Aug 01; 62(4):239-45. PubMed ID: 2969671
    [Abstract] [Full Text] [Related]

  • 18. [Effect of the angiotensin-converting enzyme inhibitor ramipril on proteinuria, blood pressure and kidney function in histologically confirmed glomerulonephritis with nephrotic syndrome].
    Götz R, Drechsler U, Heidbreder E, Heidland A.
    Z Kardiol; 1988 Aug 01; 77 Suppl 3():65-8. PubMed ID: 2975097
    [No Abstract] [Full Text] [Related]

  • 19. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
    Hodsman GP, Brown JJ, Cumming AM, Davies DL, East BW, Lever AF, Morton JJ, Murray GD, Robertson JI.
    Am J Med; 1984 Aug 20; 77(2A):52-60. PubMed ID: 6089557
    [Abstract] [Full Text] [Related]

  • 20. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC, Tarazi RC, Novick AC, Bravo EL, Fouad FM.
    Am J Med; 1984 May 31; 76(5B):29-37. PubMed ID: 6328984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.